Benzinga | Sep 28, 2020 07:01AM EDT

HC Wainwright & Co. Maintains Buy on Aquestive Therapeutics, Lowers Price Target to $14

HC Wainwright & Co. maintains Aquestive Therapeutics (NASDAQ:AQST) with a Buy and lowers the price target from $15 to $14.